Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 43Myelodysplastic Syndromes 41Leukemia 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Non-Hodgkin 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Leukemia, Lymphocytic, Chronic, B-Cell 23Lymphoma 22Hodgkin Disease 22Hematologic Neoplasms 22Multiple Myeloma 18Graft vs Host Disease 14Myeloproliferative Disorders 13Primary Myelofibrosis 12Leukemia, Myelomonocytic, Juvenile 11Lymphoma, Mantle-Cell 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myelomonocytic, Chronic 7Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myeloid, Accelerated Phase 6Congenital Abnormalities 6Burkitt Lymphoma 6Waldenstrom Macroglobulinemia 5Neuroblastoma 5Neoplasms 5Lymphoma, T-Cell, Cutaneous 5Leukemia, Myeloid, Chronic-Phase 5Blast Crisis 5

Interventions

Rituximab 112Cyclophosphamide 103fludarabine 61Doxorubicin 33Vincristine 31Etoposide 31Prednisone 30Lenalidomide 24ibrutinib 22fludarabine phosphate 21Immunotherapy, Adoptive 19Bendamustine Hydrochloride 19obinutuzumab 18Cytarabine 18pembrolizumab 16Magnetic Resonance Spectroscopy 16Bortezomib 14Specimen Handling 13Dexamethasone 13polatuzumab vedotin 12CT-P10 12venetoclax 11pirtobrutinib 11Gemcitabine 11Carboplatin 11glofitamab 10zanubrutinib 9Nivolumab 9Mycophenolic Acid 9Melphalan 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, B-Cell × thymoglobulin × Clear all
NCT01701986 2025-02-28

Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

M.D. Anderson Cancer Center

Phase 1/2 Completed
64 enrolled 13 charts
Lymphoid

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, T-Cell

NCT02424968 2021-06-24

CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

Stanford University

Phase 2 Completed
18 enrolled 16 charts
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡